Stephanie Okey
Director/Board Member presso PTC THERAPEUTICS, INC.
Patrimonio netto: 567 891 $ in data 31/03/2024
Profilo
Stephanie Smith Okey is an Independent Director who currently holds positions at PTC Therapeutics, Inc., Catalent, Inc., and Crinetics Pharmaceuticals, Inc. She previously held positions as a Director at Orphazyme A, an Independent Director at Albireo Pharma, Inc., and a Director at California Life Sciences Association.
She also served as the GM-Rare Disease Business Unit & Senior VP at Genzyme Corp.
Ms. Okey received her undergraduate degree from The Ohio State University and her graduate degree from Wright State University (Ohio).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.01% | 15/02/2024 | 9 867 ( 0.01% ) | 287 031 $ | 31/03/2024 |
| 28/03/2024 | 6 000 ( 0.01% ) | 280 860 $ | 31/03/2024 |
Posizioni attive di Stephanie Okey
| Società | Posizione | Inizio |
|---|---|---|
| PTC THERAPEUTICS, INC. | Director/Board Member | 18/12/2018 |
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 15/07/2019 |
| CATALENT, INC. | Director/Board Member | 29/08/2023 |
Precedenti posizioni note di Stephanie Okey
| Società | Posizione | Fine |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 02/03/2023 |
| ORPHAZYME A/S | Director/Board Member | 23/05/2022 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | 01/01/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2015 |
Formazione di Stephanie Okey
| The Ohio State University | Undergraduate Degree |
| Wright State University (Ohio) | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| CATALENT, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
- Borsa valori
- Insiders
- Stephanie Okey
